Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00884741 · BASELINE

Baseline characteristics

Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma · Source last updated 2019-07-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      29
    2. group Id
      BG001
      value
      309
    3. group Id
      BG002
      value
      312
    4. group Id
      BG003
      value
      650
    units
    Participants
groups
  1. description
    Temozolomide pre-randomization, radiation therapy pre-randomization. Note that for the purpose of this table, this arm only includes patients that did not continue to randomization.
    id
    BG000
    title
    Pre-Randomization TMZ+RT
  2. description
    Temozolomide post-randomization,Radiation therapy post-randomization, placebo
    id
    BG001
    title
    Randomized Arm 1: TMZ+RT + Placebo
  3. description
    Temozolomide post-randomization, radiation therapy post-randomization, bevacizumab
    id
    BG002
    title
    Randomized Arm 2: TMZ+RT + Bevacizumab
  4. description
    Total of all reporting groups
    id
    BG003
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          25
          upper Limit
          75
          value
          58
        2. group Id
          BG001
          lower Limit
          19
          upper Limit
          82
          value
          57
        3. group Id
          BG002
          lower Limit
          21
          upper Limit
          82
          value
          59
        4. group Id
          BG003
          lower Limit
          19
          upper Limit
          82
          value
          58
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          11
        2. group Id
          BG001
          value
          115
        3. group Id
          BG002
          value
          134
        4. group Id
          BG003
          value
          260
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          18
        2. group Id
          BG001
          value
          194
        3. group Id
          BG002
          value
          178
        4. group Id
          BG003
          value
          390
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
All eligible patients. Note that the Pre-Randomization TMZ+RT arm only includes eligible patients that did not continue to randomization.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      29
    2. group Id
      BG001
      value
      309
    3. group Id
      BG002
      value
      312
    4. group Id
      BG003
      value
      650
    units
    Participants
groups
  1. description
    Temozolomide pre-randomization, radiation therapy pre-randomization. Note that for the purpose of this table, this arm only includes patients that did not continue to randomization.
    id
    BG000
    title
    Pre-Randomization TMZ+RT
  2. description
    Temozolomide post-randomization,Radiation therapy post-randomization, placebo
    id
    BG001
    title
    Randomized Arm 1: TMZ+RT + Placebo
  3. description
    Temozolomide post-randomization, radiation therapy post-randomization, bevacizumab
    id
    BG002
    title
    Randomized Arm 2: TMZ+RT + Bevacizumab
  4. description
    Total of all reporting groups
    id
    BG003
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          25
          upper Limit
          75
          value
          58
        2. group Id
          BG001
          lower Limit
          19
          upper Limit
          82
          value
          57
        3. group Id
          BG002
          lower Limit
          21
          upper Limit
          82
          value
          59
        4. group Id
          BG003
          lower Limit
          19
          upper Limit
          82
          value
          58
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          11
        2. group Id
          BG001
          value
          115
        3. group Id
          BG002
          value
          134
        4. group Id
          BG003
          value
          260
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          18
        2. group Id
          BG001
          value
          194
        3. group Id
          BG002
          value
          178
        4. group Id
          BG003
          value
          390
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
All eligible patients. Note that the Pre-Randomization TMZ+RT arm only includes eligible patients that did not continue to randomization.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice